Treatment of oligometastatic breast cancer: The role of patient selection
Up to 90 % of death from solid tumors are caused by metastases. By 2040, breast cancer (BC) is predicted to increase to over 3 million new cases. Additionally, with the personalization and intensification of BC follow-up, many patients will relapse with oligometastatic disease (OMD). Over the past d...
Saved in:
Main Authors: | Riccardo Ray Colciago, Maria Carmen De Santis, Carlotta Giandini, Maria Grazia Carnevale, Serena Di Cosimo |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-02-01
|
Series: | Breast |
Online Access: | http://www.sciencedirect.com/science/article/pii/S096097762400170X |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical efficacy of cytoreductive radical prostatectomy in the treatment of oligometastatic hormone-sensitive prostate cancer
by: Feng Qi, et al.
Published: (2025-01-01) -
Oligometastatic Disease at Presentation or Recurrence for Nonsmall Cell Lung Cancer
by: Daniel R. Gomez, et al.
Published: (2012-01-01) -
Characterization of the genomic landscape in liver oligometastatic NSCLC
by: Rongxin Liao, et al.
Published: (2025-01-01) -
Local consolidative therapy in oligometastatic non-small-cell lung cancer after effective systemic treatment: who will benefit?
by: Jiayi Deng, et al.
Published: (2025-01-01) -
Impact of Immune Checkpoint Inhibitors and Local Radical Treatment on Survival Outcomes in Synchronous Oligometastatic NSCLC
by: Mandy Jongbloed, MD, et al.
Published: (2025-03-01)